Wedbush Securities Inc Astrazeneca PLC Transaction History

Wedbush Securities Inc

  • $3.06 Billion
  • Q3 2025

A detailed history of Wedbush Securities Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Wedbush Securities Inc holds 11,192 shares of AZN stock, worth $1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
11,192
Previous 8,627 29.73%
Holding current value
$1 Million
Previous $603,000 42.45%
% of portfolio
0.03%
Previous 0.02%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025
BUY
$68.72 - $82.11 $176,266 - $210,612
2,565 Added 29.73%
11,192 $859,000
Q2 2025

Aug 06, 2025
BUY
$64.87 - $75.0 $29,969 - $34,650
462 Added 5.66%
8,627 $603,000
Q1 2025

May 06, 2025
BUY
$65.37 - $77.96 $141,591 - $168,861
2,166 Added 36.11%
8,165 $600,000
Q4 2024

Feb 12, 2025
SELL
$63.2 - $79.58 $94,610 - $119,131
-1,497 Reduced 19.97%
5,999 $393,000
Q3 2024

Nov 08, 2024
SELL
$76.67 - $87.62 $1.19 Million - $1.36 Million
-15,566 Reduced 67.5%
7,496 $584,000
Q2 2024

Aug 06, 2024
BUY
$66.81 - $80.83 $37,146 - $44,941
556 Added 2.47%
23,062 $1.8 Million
Q1 2024

May 14, 2024
BUY
$61.03 - $69.57 $884,935 - $1.01 Million
14,500 Added 181.11%
22,506 $1.53 Million
Q4 2023

Feb 12, 2024
SELL
$61.89 - $69.28 $27,912 - $31,245
-451 Reduced 5.33%
8,006 $539,000
Q3 2023

Nov 14, 2023
SELL
$64.85 - $71.7 $12,191 - $13,479
-188 Reduced 2.17%
8,457 $573,000
Q2 2023

Aug 14, 2023
SELL
$69.91 - $75.81 $202,319 - $219,394
-2,894 Reduced 25.08%
8,645 $619,000
Q1 2023

May 09, 2023
SELL
$63.15 - $71.6 $119,921 - $135,968
-1,899 Reduced 14.13%
11,539 $801,000
Q4 2022

Jan 31, 2023
SELL
$54.21 - $70.44 $92,753 - $120,522
-1,711 Reduced 11.29%
13,438 $911,000
Q3 2022

Oct 18, 2022
SELL
$53.02 - $135.75 $34,038 - $87,151
-642 Reduced 4.07%
15,149 $830,000
Q2 2022

Jul 21, 2022
BUY
$59.26 - $71.14 $45,215 - $54,279
763 Added 5.08%
15,791 $1.04 Million
Q1 2022

Apr 19, 2022
BUY
$55.72 - $67.12 $46,637 - $56,179
837 Added 5.9%
15,028 $996,000
Q4 2021

Jan 13, 2022
SELL
$54.02 - $63.83 $78,869 - $93,191
-1,460 Reduced 9.33%
14,191 $826,000
Q3 2021

Oct 08, 2021
BUY
$55.56 - $60.79 $182,292 - $199,451
3,281 Added 26.52%
15,651 $939,000
Q2 2021

Jul 27, 2021
SELL
$48.42 - $60.18 $69,192 - $85,997
-1,429 Reduced 10.36%
12,370 $740,000
Q1 2021

Apr 26, 2021
BUY
$47.16 - $54.44 $50,791 - $58,631
1,077 Added 8.47%
13,799 $686,000
Q4 2020

Feb 16, 2021
BUY
$48.52 - $58.02 $3,978 - $4,757
82 Added 0.65%
12,722 $636,000
Q3 2020

Oct 20, 2020
BUY
$53.07 - $61.1 $70,423 - $81,079
1,327 Added 11.73%
12,640 $693,000
Q2 2020

Jul 16, 2020
BUY
$43.1 - $55.31 $31,850 - $40,874
739 Added 6.99%
11,313 $598,000
Q1 2020

Apr 17, 2020
BUY
$37.79 - $51.33 $54,568 - $74,120
1,444 Added 15.82%
10,574 $472,000
Q4 2019

Jan 16, 2020
SELL
$42.46 - $50.46 $17,663 - $20,991
-416 Reduced 4.36%
9,130 $455,000
Q3 2019

Oct 17, 2019
SELL
$40.12 - $45.47 $18,013 - $20,416
-449 Reduced 4.49%
9,546 $425,000
Q2 2019

Aug 01, 2019
SELL
$37.28 - $41.68 $11,705 - $13,087
-314 Reduced 3.05%
9,995 $413,000
Q1 2019

Apr 17, 2019
BUY
$35.49 - $43.02 $3,868 - $4,689
109 Added 1.07%
10,309 $417,000
Q4 2018

Jan 31, 2019
BUY
$36.86 - $41.49 $84,778 - $95,427
2,300 Added 29.11%
10,200 $387,000
Q3 2018

Nov 13, 2018
SELL
$34.76 - $39.72 $12,722 - $14,537
-366 Reduced 4.43%
7,900 $313,000
Q2 2018

Aug 03, 2018
SELL
$34.55 - $37.05 $3,178 - $3,408
-92 Reduced 1.1%
8,266 $290,000
Q1 2018

May 01, 2018
SELL
$32.97 - $36.63 $8,802 - $9,780
-267 Reduced 3.1%
8,358 $292,000
Q4 2017

Feb 09, 2018
SELL
$32.09 - $34.78 $92,387 - $100,131
-2,879 Reduced 25.03%
8,625 $299,000
Q3 2017

Oct 31, 2017
BUY
$28.96 - $34.0 $333,155 - $391,136
11,504
11,504 $390,000

Others Institutions Holding AZN

# of Institutions
1,501
Shares Held
501M
Call Options Held
5.59M
Put Options Held
3.18M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $277B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email